PubRank

Yasuto Itoyama

Author PubWeight™ 135.49‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007 4.82
2 Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009 3.91
3 Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology 2013 2.52
4 Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta Neuropathol 2013 1.79
5 Silent cerebral microbleeds on T2*-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 2002 1.74
6 NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. J Clin Invest 2007 1.70
7 Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells. Stem Cells 2008 1.67
8 Near-infrared spectroscopic topography as a tool to monitor motor reorganization after hemiparetic stroke: a comparison with functional MRI. Stroke 2002 1.63
9 Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy. Mol Neurodegener 2012 1.63
10 Activity in the lateral prefrontal cortex reflects multiple steps of future events in action plans. Neuron 2006 1.61
11 The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica. Brain Pathol 2014 1.60
12 Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica. Tohoku J Exp Med 2006 1.46
13 Familial inclusion body myositis: a report on two Japanese sisters. Intern Med 2003 1.45
14 Pure optic-spinal form of multiple sclerosis in Japan. Brain 2002 1.41
15 MRI findings from a case of fulminating adult-onset measles encephalitis. Intern Med 2006 1.40
16 Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis 2002 1.34
17 NEDL1, a novel ubiquitin-protein isopeptide ligase for dishevelled-1, targets mutant superoxide dismutase-1. J Biol Chem 2003 1.30
18 Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice. Biochem Biophys Res Commun 2003 1.28
19 Disease progression of human SOD1 (G93A) transgenic ALS model rats. J Neurosci Res 2006 1.24
20 Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 2012 1.21
21 Representation of immediate and final behavioral goals in the monkey prefrontal cortex during an instructed delay period. Cereb Cortex 2005 1.21
22 Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J Neurochem 2006 1.17
23 Neuro-Sweet disease: clinical manifestations and criteria for diagnosis. Neurology 2005 1.17
24 DNA single-strand break repair is impaired in aprataxin-related ataxia. Ann Neurol 2007 1.14
25 Loss of ALS2/Alsin exacerbates motor dysfunction in a SOD1-expressing mouse ALS model by disturbing endolysosomal trafficking. PLoS One 2010 1.12
26 Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis. J Neurol 2007 1.12
27 Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J Psychosom Res 2006 1.07
28 Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death. J Biol Chem 2008 1.07
29 Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients. J Neuroimmunol 2005 1.07
30 The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein. PLoS One 2011 1.06
31 Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody. J Neurol 2009 1.05
32 Eugène Devic (1858-1930). J Neurol 2002 1.05
33 Two subtypes of optic-spinal form of multiple sclerosis in Japan: clinical and laboratory features. J Neurol 2007 1.04
34 Transient increases in anti-aquaporin-4 antibody titers following rituximab treatment in neuromyelitis optica, in association with elevated serum BAFF levels. J Clin Neurosci 2011 1.02
35 Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis. Mult Scler 2004 1.00
36 Cell cycle protein expression in proliferating microglia and astrocytes following transient global cerebral ischemia in the rat. Brain Res Bull 2003 1.00
37 Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Mov Disord 2009 1.00
38 CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol 2004 0.99
39 Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension. BMC Neurol 2014 0.98
40 Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006 0.98
41 Arg(184)His mutant GTP cyclohydrolase I, causing recessive hyperphenylalaninemia, is responsible for dopa-responsive dystonia with parkinsonism: a case report. Mov Disord 2004 0.97
42 Development of a high-throughput microarray-based resequencing system for neurological disorders and its application to molecular genetics of amyotrophic lateral sclerosis. Arch Neurol 2008 0.97
43 FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion. J Hum Genet 2010 0.96
44 [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview]. Brain Nerve 2008 0.96
45 Alteration in calcium channel properties is responsible for the neurotoxic action of a familial frontotemporal dementia tau mutation. J Neurochem 2003 0.96
46 Alteration of familial ALS-linked mutant SOD1 solubility with disease progression: its modulation by the proteasome and Hsp70. Biochem Biophys Res Commun 2006 0.95
47 Survival and death-promoting events after transient spinal cord ischemia in rabbits: induction of Akt and caspase3 in motor neurons. J Thorac Cardiovasc Surg 2003 0.94
48 Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells. Brain Res 2004 0.93
49 Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B. J Neurol Neurosurg Psychiatry 2012 0.93
50 Impaired chemosensitivity to hypoxia is a marker of multiple system atrophy. Ann Neurol 2002 0.93
51 Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis. J Neurosci Res 2010 0.92
52 Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Brain Res 2004 0.92
53 Two cases of elderly-onset hereditary neuropathy with liability to pressure palsy manifesting bilateral peroneal nerve palsies. Case Rep Neurol 2012 0.91
54 Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease. FEBS Lett 2006 0.90
55 Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis. J Neurol Sci 2010 0.90
56 Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease. Mov Disord 2011 0.90
57 Effect of low-voltage electrical stimulation on angiogenic growth factors in ischaemic rat skeletal muscle. Clin Exp Pharmacol Physiol 2006 0.89
58 Motor neuron disease in transgenic mice with an H46R mutant SOD1 gene. J Neuropathol Exp Neurol 2007 0.88
59 A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice. Exp Neurol 2008 0.88
60 Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis. J Neuroimmunol 2004 0.88
61 Do parkinsonian patients have trouble telling lies? The neurobiological basis of deceptive behaviour. Brain 2009 0.88
62 Accumulation of chondroitin sulfate proteoglycans in the microenvironment of spinal motor neurons in amyotrophic lateral sclerosis transgenic rats. J Neurosci Res 2008 0.87
63 Two cases of lumbosacral myeloradiculitis with anti-aquaporin-4 antibody. Neurology 2012 0.87
64 Mechanisms of neuronal death in synucleinopathy. J Biomed Biotechnol 2006 0.87
65 Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J Immunol 2003 0.87
66 An in vitro model for Lewy body-like hyaline inclusion/astrocytic hyaline inclusion: induction by ER stress with an ALS-linked SOD1 mutation. PLoS One 2007 0.87
67 CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha. J Neuroimmunol 2004 0.87
68 Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathol 2005 0.86
69 White matter involvement in idiopathic normal pressure hydrocephalus: a voxel-based diffusion tensor imaging study. J Neurol 2011 0.86
70 Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy. Neurochem Int 2010 0.86
71 Transethmoidal intranasal meningoencephalocele in an adult with recurrent meningitis. J Clin Neurosci 2005 0.86
72 Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites. FEBS Lett 2007 0.86
73 Analysis of the full-length genome of hepatitis B virus in the serum and cerebrospinal fluid of a patient with acute hepatitis B and transverse myelitis. J Clin Virol 2008 0.85
74 Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 2014 0.85
75 Histological evidence of redox system breakdown caused by superoxide dismutase 1 (SOD1) aggregation is common to SOD1-mutated motor neurons in humans and animal models. Acta Neuropathol 2003 0.85
76 Endoplasmic reticulum stress induced in motor neurons by transient spinal cord ischemia in rabbits. J Thorac Cardiovasc Surg 2005 0.85
77 Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Eur Neuropsychopharmacol 2005 0.85
78 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages. J Clin Neurosci 2006 0.84
79 Oxidative damage and reduction of redox factor-1 expression after transient spinal cord ischemia in rabbits. J Vasc Surg 2003 0.84
80 Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase. J Neurochem 2003 0.84
81 Influence of ischemic preconditioning on levels of nerve growth factor, brain-derived neurotrophic factor and their high-affinity receptors in hippocampus following forebrain ischemia. Brain Res 2007 0.84
82 Late-onset distal myopathy with rimmed vacuoles without mutation in the GNE or dysferlin genes. Muscle Nerve 2005 0.83
83 Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET study. PLoS One 2012 0.83
84 Dendritic cells in muscle lesions of sarcoidosis. Hum Pathol 2010 0.83
85 [A recalcitrant case of encephalitis with voltage-gated potassium channel antibodies]. Brain Nerve 2010 0.83
86 Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica. J Neuroimmunol 2012 0.83
87 Chemokine profile in the cerebrospinal fluid and serum of Vogt-Koyanagi-Harada disease. J Neuroimmunol 2005 0.83
88 MCI-186 reduces oxidative cellular damage and increases DNA repair function in the rabbit spinal cord after transient ischemia. Ann Thorac Surg 2004 0.82
89 Novel dysferlin mutations and characteristic muscle atrophy in late-onset Miyoshi myopathy. Muscle Nerve 2004 0.82
90 Prognostic value of cerebrospinal fluid cytokine changes in herpes simplex virus encephalitis. Cytokine 2009 0.82
91 Relapsing focal myositis: the localization detected by gallium citrate Ga 67 scintigraphy. Arch Neurol 2005 0.82
92 Heme catabolism and heme oxygenase in neurodegenerative disease. Antioxid Redox Signal 2004 0.82
93 In vivo visualization of alpha-synuclein deposition by carbon-11-labelled 2-[2-(2-dimethylaminothiazol-5-yl)ethenyl]-6-[2-(fluoro)ethoxy]benzoxazole positron emission tomography in multiple system atrophy. Brain 2010 0.82
94 Development of a rat model of amyotrophic lateral sclerosis expressing a human SOD1 transgene. Neuropathology 2005 0.82
95 Expression profiling with progression of dystrophic change in dysferlin-deficient mice (SJL). Neurosci Res 2005 0.82
96 [Nationwide questionnaire study in "the Model Core Curriculum" and current status for the undergraduate education in neurology]. Rinsho Shinkeigaku 2008 0.81
97 Heterogeneity and continuum of multiple sclerosis phenotypes in Japanese according to the results of the fourth nationwide survey. J Neurol Sci 2009 0.81
98 Effects of 10-T static magnetic field on human peripheral blood immune cells. Radiat Res 2003 0.80
99 Distal anterior compartment myopathy with early ankle contractures. Muscle Nerve 2007 0.80
100 Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. J Neuropathol Exp Neurol 2007 0.80
101 Th1/Th2 balance and HTLV-I proviral load in HAM/TSP patients treated with interferon-alpha. J Neuroimmunol 2004 0.80
102 MCI-186 prevents spinal cord damage and affects enzyme levels of nitric oxide synthase and Cu/Zn superoxide dismutase after transient ischemia in rabbits. J Thorac Cardiovasc Surg 2003 0.80
103 Feasibility study for functional test battery of SOD transgenic rat (H46R) and evaluation of edaravone, a free radical scavenger. Brain Res 2011 0.80
104 Successful treatment of a hypothalamic lesion in neuromyelitis optica by plasma exchange. J Neurol 2007 0.80
105 Neutralizing antibodies are associated with a reduction of interferon-β efficacy during the treatment of Japanese multiple sclerosis patients. Tohoku J Exp Med 2012 0.80
106 A case of McArdle disease: efficacy of vitamin B6 on fatigability and impaired glycogenolysis. Intern Med 2010 0.79
107 Motoneuron degeneration after facial nerve avulsion is exacerbated in presymptomatic transgenic rats expressing human mutant Cu/Zn superoxide dismutase. J Neurosci Res 2005 0.79
108 Expression of OX40 in muscles of polymyositis and granulomatous myopathy. J Neurol Sci 2002 0.79
109 A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica. Tohoku J Exp Med 2008 0.79
110 Herpes labialis in multiple sclerosis with a trigeminal lesion. Intern Med 2011 0.79
111 Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions. Mult Scler 2012 0.79
112 A case of dysferlinopathy presenting choreic movements. Mov Disord 2006 0.79
113 [Chemokines and chemokine receptors in multiple sclerosis]. Nihon Rinsho 2003 0.79
114 Therapeutic efficacy of interferon β-1b in Japanese patients with optic-spinal multiple sclerosis. Tohoku J Exp Med 2011 0.79
115 Continuous administration of poloxamer 188 reduces overload-induced muscular atrophy in dysferlin-deficient SJL mice. Neurosci Res 2011 0.79
116 [A case of Marchiafava-Bignami disease: serial changes with diffusion-weighted MR imaging]. Rinsho Shinkeigaku 2002 0.79
117 Functional imaging studies of hyposmia in Parkinson's disease. J Neurol Sci 2009 0.78
118 Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis. Exp Neurol 2005 0.78
119 Safety and efficacy of interferon-alpha in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy. J Neurovirol 2007 0.78
120 Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis. J Neurol Sci 2006 0.78
121 CCR7+ myeloid dendritic cells together with CCR7+ T cells and CCR7+ macrophages invade CCL19+ nonnecrotic muscle fibers in inclusion body myositis. J Neurol Sci 2009 0.78
122 Up-regulation of insulin-like growth factor-II receptor in reactive astrocytes in the spinal cord of amyotrophic lateral sclerosis transgenic rats. Tohoku J Exp Med 2008 0.78
123 Illusory misidentifications and cortical hypometabolism in Parkinson's disease. Mov Disord 2011 0.78
124 Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease. J Neurol Sci 2003 0.78
125 Periodic episodes of aphasia as an unusual manifestation of partial status epilepticus. J Clin Neurosci 2005 0.77
126 Alteration of cystatin C in the cerebrospinal fluid of multiple sclerosis. Ann Neurol 2007 0.77
127 Interferon-alpha significantly reduces cerebrospinal fluid CD4 cell subsets in HAM/TSP. J Neuroimmunol 2003 0.77
128 Involvement of activated microglia in increased vulnerability of motoneurons after facial nerve avulsion in presymptomatic amyotrophic lateral sclerosis model rats. Glia 2012 0.77
129 Epitope analysis of cerebrospinal fluid IgG in Japanese multiple sclerosis patients using phage display method. Mult Scler Int 2011 0.77
130 Mitochondrial alterations in transgenic mice with an H46R mutant Cu/Zn superoxide dismutase gene. J Neuropathol Exp Neurol 2009 0.77
131 Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline. J Med Virol 2003 0.77
132 Neuromagnetic localization of spike sources in perilesional, contralateral mirror, and ipsilateral remote areas in patients with cavernoma. Epilepsia 2007 0.77
133 Altered expression of Th1-type chemokine receptor CXCR3 on CD4+ T cells in myasthenia gravis patients. J Neuroimmunol 2006 0.76
134 [Laboratory and imaging studies for the diagnosis of prion disease]. Rinsho Shinkeigaku 2003 0.76
135 Association between a polymorphism of brain-derived neurotrophic factor gene and sporadic Parkinson's disease. Ann Neurol 2003 0.75
136 Candidate antigens specifically detected by cerebrospinal fluid-IgG in oligoclonal IgG bands-positive multiple sclerosis patients. Proteomics Clin Appl 2007 0.75
137 [Amyotrophic lateral sclerosis with the SOD1 mutations]. Rinsho Shinkeigaku 2008 0.75
138 Recurrent hypogeusia in a patient with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J Clin Neurosci 2012 0.75
139 Hypometabolism in the supplementary and anterior cingulate cortices is related to dysphagia in Parkinson's disease: a cross-sectional and 3-year longitudinal cohort study. BMJ Open 2013 0.75
140 Soluble CD26 and CD30 levels in CSF and sera of patients with relapsing neuromyelitis optica. J Neurol 2005 0.75
141 Altered populations of natural killer cell and natural killer T cell subclasses in myasthenia gravis. J Neuroimmunol 2005 0.75
142 [A case of cryptococcal meningitis presenting initially as bilateral hearing loss]. No To Shinkei 2004 0.75
143 Spade-shaped vocal cord in a multiple system atrophy patient with nocturnal stridor. Intern Med 2007 0.75
144 [Late-onset nonketotic hyperglycinemia: a case report]. No To Shinkei 2002 0.75
145 [Clinical translation of hepatocyte growth factor for amyotrophic lateral sclerosis]. Rinsho Shinkeigaku 2012 0.75
146 [T2*-weighted MRI in cerebrovascular disease]. No To Shinkei 2002 0.75
147 Dorsal-roots enhancement and Wallerian degeneration of dorsal cord in the patient of acute sensory ataxic neuropathy. J Neurol 2009 0.75
148 Transient cytotoxic edema in the splenium of the corpus callosum. Intern Med 2010 0.75
149 [Encephalitis and encephalopathy: progress in their diagnosis and treatment]. Nihon Naika Gakkai Zasshi 2006 0.75
150 [Changing concepts of optic-spinal multiple sclerosis (OSMS)]. Rinsho Shinkeigaku 2007 0.75
151 [Case of Neuro-Behçet disease resembling bacterial meningitis]. Rinsho Shinkeigaku 2008 0.75
152 [Magnetic resonance imaging for the diagnosis of multiple sclerosis]. Nihon Rinsho 2003 0.75
153 [Pathophysiological process underlying Parkinson's disease: motor & non-motor symptoms]. Rinsho Shinkeigaku 2009 0.75
154 Pathogenesis of Neuromyelitis Optica: aquaporin 4 autoimmunity and astrocytopathy. Rinsho Shinkeigaku 2010 0.75
155 [Regenerative therapies for amyotrophic lateral sclerosis using hepatocyte growth factor]. Rinsho Shinkeigaku 2011 0.75
156 [A case of hypokalemic periodic paralysis: utility of exercise test for the assessment of therapeutic efficacy]. No To Shinkei 2003 0.75
157 [Toxoplasma encephalitis in a patient receiving cyclosporine monotherapy for Behçet disease]. Rinsho Shinkeigaku 2005 0.75
158 [Progress in the field of neurology in the last 100 years: History of research in multiple sclerosis]. Nihon Naika Gakkai Zasshi 2002 0.75
159 Intravenous immunoglobulin treatment successfully improved subacute progressive polyradiculoneuropathy with polyclonal gammopathy. Intern Med 2009 0.75
160 [A marked decrease of orexin in the cerebrospinal fluid in a patient with myotonic dystrophy type 1 showing an excessive daytime sleepiness]. Rinsho Shinkeigaku 2009 0.75
161 [A case of neuralgic amyotrophy manifesting bilateral anterior interosseous nerve syndrome]. No To Shinkei 2002 0.75
162 [Elevated serum aldolase activity in a patient of non-eosinophilic myofasciitis and synovitis with perifascicular atrophy]. Rinsho Shinkeigaku 2009 0.75
163 [Multiple sclerosis and oligoclonal IgG bands]. No To Shinkei 2004 0.75
164 [Case of multiple sclerosis with "yes-yes" type head tremor]. Rinsho Shinkeigaku 2011 0.75
165 [Development of motor neuron restorative therapy in amyotrophic lateral sclerosis using hepatocyte growth factor]. Rinsho Shinkeigaku 2009 0.75
166 [MR spectroscopy findings of a case of intravascular malignant lymphoma: usefulness for differential diagnosis]. Rinsho Shinkeigaku 2003 0.75
167 [New insights into the pathogenesis of neuromyelitis optica]. Brain Nerve 2010 0.75
168 [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis]. Rinsho Byori 2009 0.75
169 [Pathogenesis of optic-spinal MS]. Rinsho Shinkeigaku 2002 0.75
170 [A concept of neuromyelitis optica in Japan]. Brain Nerve 2010 0.75
171 [Postgraduate education for neurologists in hospitals authorized by the Japanese Society of Neurology]. Rinsho Shinkeigaku 2006 0.75
172 FALS with FUS mutation in Japan, with early onset, rapid progress and basophilic inclusion. J Hum Genet 2015 0.75
173 [Massive bleeding from tracheoarterial fistula in an amyotrophic lateral sclerosis patient treated with long-term invasive ventilation: an autopsy case report]. Rinsho Shinkeigaku 2008 0.75